Costello Asset Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-250
Closed -$2K – 221
2022
Q3
$2K Hold
250
– – ﹤0.01% 202
2022
Q2
$2K Hold
250
– – ﹤0.01% 210
2022
Q1
$2K Hold
250
– – ﹤0.01% 223
2021
Q4
$2K Hold
250
– – ﹤0.01% 228
2021
Q3
$2K Hold
250
– – ﹤0.01% 215
2021
Q2
$2K Buy
+250
New +$2.65K ﹤0.01% 213

Other funds holding TEVA

Costello Asset Management's TEVA Position: Q4 2022 in Review

Costello Asset Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2022, closing a stake of 250 shares — an estimated $2K sold.

Costello Asset Management first reported a position in TEVA in Q2 2021 and held it in 6 quarters. The position peaked at $2K in Q3 2022. 421 funds tracked by Wall St. Rank hold TEVA as of Q4 2022.

  • Costello Asset Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2022 after selling out during the quarter.
  • Costello Asset Management sold 250 Teva Pharmaceutical Industries Limited shares in Q4 2022, an estimated $2K.
  • Costello Asset Management first reported a position in Teva Pharmaceutical Industries Limited in Q2 2021 and held it in 6 quarters.
  • Costello Asset Management's Teva Pharmaceutical Industries Limited position peaked at $2K in Q3 2022.
  • 421 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2022.

Based on Costello Asset Management's 13F filing for Q4 2022, filed 2 Feb 2023.